MacroGenics
MGNX
131 hedge funds and large institutions have $321M invested in MacroGenics in 2023 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 41 increasing their positions, 47 reducing their positions, and 23 closing their positions.
2.54% more ownership
Funds ownership: 94.51% → 97.05% (+2.5%)
4% less funds holding
Funds holding: 137 → 131 (-6)
13% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 47
23% less capital invested
Capital invested by funds: $419M → $321M (-$97.9M)
26% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 23
68% less call options, than puts
Call options by funds: $197K | Put options by funds: $625K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$15.7M |
| 2 |
JP Morgan Chase
New York
|
+$6.46M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
+$2.25M |
| 4 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$2.17M |
| 5 |
Vontobel Holding
Zurich,
Switzerland
|
+$2.17M |
Top Sellers
| 1 |
Millennium Management
New York
|
-$5.8M |
| 2 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$4.59M |
| 3 |
EC
EcoR1 Capital
San Francisco,
California
|
-$4.44M |
| 4 |
Two Sigma Advisers
New York
|
-$2.5M |
| 5 |
Two Sigma Investments
New York
|
-$2.28M |
MGNX Hedge Fund Activity: Q2 2023 in Review
131 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q2 2023, worth a combined $321M — down 23% from $419M a quarter earlier.
Sellers outnumbered buyers: 23 funds closed out of MGNX and 17 opened new positions — a net loss of 6 holders — while 47 trimmed existing stakes and 41 added.
The largest buyer was T. Rowe Price Investment Management, adding an estimated $15.7M. The largest seller was Millennium Management, cutting an estimated $5.8M.
- 131 institutional investors held MacroGenics (MGNX) as of Q2 2023, down from 137 in Q1 2023.
- Funds reported $321M of MacroGenics stock for Q2 2023, down 23% quarter-over-quarter.
- 17 funds opened new MacroGenics positions in Q2 2023 and 23 closed out, a net change of -6 holders.
- The largest MacroGenics buyer in Q2 2023 was T. Rowe Price Investment Management, an estimated $15.7M added.
- The largest MacroGenics seller in Q2 2023 was Millennium Management, an estimated $5.8M sold.
Based on aggregated 13F filings for Q2 2023.